Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA Jr, Rudolph U. Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology. 2012 Oct;37(11):2531-40. doi: 10.1038/npp.2012.115. Epub 2012 Jul 4. PubMed PMID: 22763624; PubMed Central PMCID: PMC3442348.
Engin E, Bakhurin KI, Smith KS, Hines RM, Reynolds LM, Tang W, Sprengel R, Moss SJ, Rudolph U. Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens. Neuropsychopharmacology. 2014 Jul;39(8):1805-15. doi: 10.1038/npp.2014.41. Epub 2014 Feb 19. PubMed PMID: 24553732; PubMed Central PMCID: PMC4059902.
Reynolds LM, Makowski CS, Yogendran SV, Kiessling S, Cermakian N, Flores C. Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner. Neuropsychopharmacology. 2015 Mar 13;40(5):1101-12. doi: 10.1038/npp.2014.287. PubMed PMID: 25336209; PubMed Central PMCID: PMC4367452.
Reynolds LM, Gifuni AJ, McCrea ET, Shizgal P, Flores C. dcc Haploinsufficiency results in blunted sensitivity to cocaine enhancement of reward seeking. Behav Brain Res. 2016 Feb 1;298(Pt A):27-31. doi: 10.1016/j.bbr.2015.05.020. Epub 2015 May 22. PubMed PMID: 26005129.
Madularu D, Mathieu AP, Kumaragamage C, Reynolds LM, Near J, Flores C, Rajah MN. A non-invasive restraining system for awake mouse imaging. J Neurosci Methods. 2017 Aug 1;287:53-57. doi: 10.1016/j.jneumeth.2017.06.008. Epub 2017 Jun 17. PubMed PMID: 28634149; PubMed Central PMCID: PMC5790991.
Normandeau CP, Naumova D, Thompson SL, Ebrahimzadeh M, Liu YQ, Reynolds L, Ren HY, Hawken ER, Dumont ÉC. Advances in understanding and treating mental illness: proceedings of the 40th Canadian College of Neuropsychopharmacology Annual Meeting Symposia. J Psychiatry Neurosci. 2017 Sep;42(5):353-358. doi: 10.1503.jpn/170120. PubMed PMID: 28834528; PubMed Central PMCID: PMC5573577.
Hoops D, Reynolds LM, Restrepo-Lozano JM, Flores C. Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence. eNeuro. 2018 Jan-Feb;5(1). doi: 10.1523/ENEURO.0372-17.2017. eCollection 2018 Jan-Feb. PubMed PMID: 29333488; PubMed Central PMCID: PMC5762649.
Reynolds LM, Pokinko M, Torres-Berrío A, Cuesta S, Lambert LC, Del Cid Pellitero E, Wodzinski M, Manitt C, Krimpenfort P, Kolb B, Flores C. DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence. Biol Psychiatry. 2018 Jan 15;83(2):181-192. doi: 10.1016/j.biopsych.2017.06.009. Epub 2017 Jun 16. PubMed PMID: 28720317; PubMed Central PMCID: PMC5723533.
Cuesta S, Restrepo-Lozano JM, Silvestrin S, Nouel D, Torres-Berrío A, Reynolds LM, Arvanitogiannis A, Flores C. Non-Contingent Exposure to Amphetamine in Adolescence Recruits miR-218 to Regulate Dcc Expression in the VTA. Neuropsychopharmacology. 2018 Mar;43(4):900-911. doi: 10.1038/npp.2017.284. Epub 2017 Nov 20. PubMed PMID: 29154364; PubMed Central PMCID: PMC5809802.
Reynolds LM, Flores C. Guidance cues: linking drug use in adolescence with psychiatric disorders. Neuropsychopharmacology. 2019 Jan;44(1):225-226. doi: 10.1038/s41386-018-0221-7. Epub 2018 Oct 1. PubMed PMID: 30275561; PubMed Central PMCID: PMC6235858.
Reynolds LM, Yetnikoff L, Pokinko M, Wodzinski M, Epelbaum JG, Lambert LC, Cossette MP, Arvanitogiannis A, Flores C. Early Adolescence is a Critical Period for the Maturation of Inhibitory Behavior. Cereb Cortex. 2019 Aug 14;29(9):3676-3686. doi: 10.1093/cercor/bhy247. PubMed PMID: 30295713; PubMed Central PMCID: PMC6686753.
Cuesta S, Nouel D, Reynolds LM, Morgunova A, Torres-Berrío A, White A, Hernandez G, Cooper HM, Flores C. Dopamine Axon Targeting in the Nucleus Accumbens in Adolescence Requires Netrin-1. Front Cell Dev Biol. 2020;8:487. doi: 10.3389/fcell.2020.00487. eCollection 2020. PubMed PMID: 32714924; PubMed Central PMCID: PMC7344302.
Cuesta S, Restrepo-Lozano JM, Popescu C, He S, Reynolds LM, Israel S, Hernandez G, Rais R, Slusher BS, Flores C. DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence. Addict Biol. 2020 Jul;25(4):e12791. doi: 10.1111/adb.12791. Epub 2019 Jun 13. PubMed PMID: 31192517; PubMed Central PMCID: PMC8301742.
Nguyen C, Mondoloni S, Le Borgne T, Centeno I, Come M, Jehl J, Solié C, Reynolds LM, Durand-de Cuttoli R, Tolu S, Valverde S, Didienne S, Hannesse B, Fiancette JF, Pons S, Maskos U, Deroche-Gamonet V, Dalkara D, Hardelin JP, Mourot A, Marti F, Faure P. Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety. Neuron. 2021 Aug 18;109(16):2604-2615.e9. doi: 10.1016/j.neuron.2021.06.013. Epub 2021 Jul 8. PubMed PMID: 34242565.
Reynolds LM, Flores C. Mesocorticolimbic Dopamine Pathways Across Adolescence: Diversity in Development. Front Neural Circuits. 2021;15:735625. doi: 10.3389/fncir.2021.735625. eCollection 2021. Review. PubMed PMID: 34566584; PubMed Central PMCID: PMC8456011.
Dongelmans M, Durand-de Cuttoli R, Nguyen C, Come M, Duranté EK, Lemoine D, Brito R, Ahmed Yahia T, Mondoloni S, Didienne S, Bousseyrol E, Hannesse B, Reynolds LM, Torquet N, Dalkara D, Marti F, Mourot A, Naudé J, Faure P. Chronic nicotine increases midbrain dopamine neuron activity and biases individual strategies towards reduced exploration in mice. Nat Commun. 2021 Nov 26;12(1):6945. doi: 10.1038/s41467-021-27268-7. PubMed PMID: 34836948; PubMed Central PMCID: PMC8635406.
What would you like to do?
  • Page of 1